Persistent Epithelial Defect Treatment Market 2024 Global Industry, Share, In-Depth Qualitative Insights, Revenue Growth by 2031 | Dompé, Santen Pharmaceutical Co., Ltd., Noveome Biotherapeutics, Inc.

DataM Intelligence has published a new research report on "Persistent Epithelial Defect Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/persistent-epithelial-defect-treatment-market

The Persistent Epithelial Defect Treatment market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Persistent Epithelial Defect Treatment refers to the medical management and therapeutic approaches aimed at addressing chronic non-healing wounds or defects in the epithelial layer of tissues, particularly in the cornea of the eye. These defects may arise from various factors such as trauma, chemical injury, infection, or underlying ocular diseases and can lead to significant discomfort and vision impairment.

Key Developments:

On April 12, 2023, the U.S. Food and Drug Administration (FDA) granted Fast Track designation to KPI-012, a human mesenchymal stem cell secretome (MSC-S) therapy developed by Kala Pharmaceuticals for the management of persistent corneal epithelial defect (PCED), a rare and debilitating ocular condition. Kala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is dedicated to discovering, developing, and marketing innovative therapies for serious eye conditions.

On January 3, 2023, RegeneRx Biopharmaceuticals, Inc. published a new scientific article detailing a phase 3 clinical study on the safety and effectiveness of RGN-259 eyedrops in patients with Neurotrophic Keratopathy (NK). This product candidate, being developed by ReGenTree, LLC, a joint venture between HLB Therapeutics and RegeneRx, demonstrated its efficacy and safety in accelerating the healing of persistent epithelial defects in patients with Stage 2 and Stage 3 NK.

On July 18, 2022, a global ophthalmology contract research organization (CRO) entered into a letter of intent with HLB Therapeutics (HLBT), the U.S. joint venture partner and licensee of RegeneRx Biopharmaceuticals, to initiate two concurrent phase 3 clinical trials for patients with neurotrophic keratitis (NK) in the U.S. and Europe.

Forecast Growth Projected:

The Global Persistent Epithelial Defect Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Persistent Epithelial Defect Treatment Market:

Dompé, Santen Pharmaceutical Co., Ltd., Noveome Biotherapeutics, Inc., Recordati Rare Diseases, Kala Pharmaceuticals, Corza Ophthalmology, Amber Ophthalmics, Kiora Pharmaceuticals, Inc., MimeTech Srl and Cordlife.

Segment Covered in the Persistent Epithelial Defect Treatment Market:

By Disease Type: Limbal Stem Cell Deficiency, Neurotrophic Keratitis, Inflammatory Disease, Defective Epithelial Adhesion, Others

By Treatment: Ophthalmic Solution (Recombinant Human NGF Eye Drops, Serum-Derived Eye Drops), Stem Cell Therapy, Amniotic Membrane Transplant

By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Regional Analysis:

The global Persistent Epithelial Defect Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/persistent-epithelial-defect-treatment-market

Regional Analysis:

The global Persistent Epithelial Defect Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Persistent Epithelial Defect Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Persistent Epithelial Defect Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Persistent Epithelial Defect Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/persistent-epithelial-defect-treatment-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.